Genetic factors for ILD—the path of precision medicine
With increasing awareness of genetic factors and variants involved in the pathogenesis of interstitial lung diseases (ILDs) and expanded availability of genetic testing, pulmonologists diagnosing and managing ILD should appreciate their clinical significance. In patients with a family health history of a similar or the same disease, the term genetic is used to imply one or more underlying genetic components to be causative of the disease with a pathogenic variant. There is a need to use terms precisely and associate pathogenic variants with the specific ILD diagnosis.